Now showing items 1-2 of 2
Immune checkpoint inhibitors-related rheumatic diseases: what rheumatologist should know?
(Bentham Science Publ Ltd, 2019)
Immune checkpoint inhibitors are revolutionized drugs for cancer immunotherapy in the last years. The mechanism of action of CPIs including the limitation of the activation of Tcells, and thus enhancing the self-immune ...
Ustekinumab-induced chronic lymphocytic leukemia in a patient with psoriatic arthritis
Abstract Psoriatic arthritis (PsA) is a chronic inflammatory disease characterized by skin and joint involvement. The disease may present with various joint pattern involvement, which sometimes may lead to joint destruction ...